Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, SCZ, CFG

Latest federal guidelines to control spread of COVID-19 in long-term care homes a welcome step; more action on seniors care needed now and going forward


OTTAWA, April, 14, 2020 /CNW/ - With nearly half of all COVID-19 deaths in Canada linked to outbreaks in long-term care homes, the Canadian Medical Association (CMA) is welcoming the new interim guidance from the federal government on infection prevention and control of the virus in these facilities. We encourage all provincial/territorial governments to adopt these guidelines uniformly across all long-term care and seniors' residences.

I'd also like to highlight some of the measures provincial governments have already implemented to safeguard the health of residents and employees in these facilities ? these include improving wages for long-term care workers in Quebec and introducing more screening and testing as well as ensuring the availability of personal protective equipment in long-term care facilities in Ontario. Ideally, we would see measures such as these applied consistently across Canada, but more support is required to make that happen.

Caring for seniors is among our top priorities under normal circumstances, but even more so during the pandemic. The CMA has long advocated for a comprehensive plan to improve seniors care in Canada, with the appropriate investments to make it a reality. With Canadians living longer than ever, the demographic shift is already having a significant impact on our health care system. And COVID-19 is an important reminder that all governments need to work together to best support and care for our seniors in this country.

Dr. Sandy Buchman, CMA president

SOURCE Canadian Medical Association


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: